Table of Contents

<< Previous Issue

May 2013 (Vol: 2013, Issue: 5)

Section: Licensing
Merck & Co. Out-Licenses Second CNS Programme to Cerecor Published: 2 May-2013
By: Heather Cartwright
Abstract Fulltext:
Section: Mergers & Acquisitions
Bayer Boosts Contraceptive Business with US$1.1 B Conceptus Purchase Published: 13 May-2013
By: Heather Cartwright
Abstract Fulltext:
Takeda Joins the Dengue Vaccine Race with Inviragen Purchase Published: 20 May-2013
By: Heather Cartwright
Abstract Fulltext:
Section: Research & Development
AstraZeneca Continues Early-Stage Deal-Making Spree with Alchemia Deal Published: 2 May-2013
By: Heather Cartwright
Abstract Fulltext:
Forma Therapeutics Partners with Celgene in its Largest Deal to Date Published: 9 May-2013
By: Heather Cartwright
Abstract Fulltext:
Merck & Co. Collaborates with Pfizer and Abide Therapeutics with Aim of Bolstering Diabetes Portfolio Published: 14 May-2013
By: Heather Cartwright
Abstract Fulltext:
Concert Pharmaceuticals Snags Celgene as a Partner for its DCE Platform® Published: 16 May-2013
By: Heather Cartwright
Abstract Fulltext:
Shire Partners with Nimbus Discovery to Develop Oral Therapies for Lysosomal Storage Disorders Published: 20 May-2013
By: Heather Cartwright
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

Bookmarks

Bookmark PharmaDeals through one of these social networks.